Skip to main content
Log in

Clinical evaluation of blue-light blocker foldable acrylic IOL (HMY)

  • Original Article
  • Published:
Annals of Ophthalmology

Abstract

Efficacy and safety of blue-light-filtering acrylic IOL (HMY) were assessed and proven from 3 months to 1 year of postoperative follow-up in a clinical study performed on 80 eyes of 45 patients. Postoperative corrected visual acuity of all the eyes was 6/12 or better and 78.8% of them achieved higher than 6/6. The rate of mean corneal endothelial cell density decrease stood at 5.0%. Mild complciations were observed, but none were serious.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leaming DV. Practice styles and preferences of ASCRS members—2003 survey. J Cataract Refract Surg. 2004;30:892–900.

    Article  PubMed  Google Scholar 

  2. Oshika T, Suzuki Y, Kizaki H, et al. Two year clinical study of a soft acrylic intraocular lens. J Cataract Refract Surg. 1996;22: 104–109.

    PubMed  CAS  Google Scholar 

  3. Niwa K, Yoshino Y, Okuyama F, et al. Effects of tinted intraocular lens on contrast sensitivity. Ophthalmic Physiol Opt. 1996;16: 297–302.

    Article  PubMed  CAS  Google Scholar 

  4. Yuan Z, Reinach P, Yuan J. Contrast sensitivity and color vision with a yellow intraocular lens. Am J Ophthalmol. 2004;138: 138–140.

    Article  PubMed  Google Scholar 

  5. Miyake K, Ichihashi S, Shibuya Y, et al. Blood-retinal barrier and autofluorescence of the posterior polar retina in long-standing pseudophakia. J Cataract Refract Surg. 1999;25:891–897.

    Article  PubMed  CAS  Google Scholar 

  6. Sparrow JR, Miller AS, Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg. 2004;30:873–878.

    Article  PubMed  Google Scholar 

  7. Neuhann TH, Weber S. Clinical 12-month outcome with the foldable, hydrophobic acrylic lens AMO AR40NB. Klin Monatsbl Augenheilkd. 1999;215:329–333.

    Article  PubMed  CAS  Google Scholar 

  8. Prosdocimo G, Tassinari G, Sala M, et al. Posterior capsule opacification after phacoemulsification: silicone CeeOn Edge versus acrylate AcrySof intraocular lens. J Cataract Refract Surg. 2003;29:1551–1555.

    Article  PubMed  Google Scholar 

  9. Miyata A, Uchida N, Nakajima K, et al. Clinical and experimental observation of glistening in acrylic intraocular lenses. Jpn J Opthalmol. 2001;45:564–569.

    Article  CAS  Google Scholar 

  10. Ishida M, Yanashima K, Miwa M, et al. Influence of the yellowtinted intraocular lens on spectral sensitivity. [Japanese] Nippon Ganka Gakkai Zasshi. 1994;98:192–196.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tsuyoshi Hibino MD.

Additional information

Disclosure The authors have stated that they do not have a significant financial interest or other relationship with any product manufacturer or provider of, services discussed in this article. The authors also do not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hibino, T., Shimomura, Y., Matsumoto, C. et al. Clinical evaluation of blue-light blocker foldable acrylic IOL (HMY). Ann Ophthalmol 38, 311–316 (2006). https://doi.org/10.1007/BF02697213

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02697213

Keywords

Navigation